Evidence map›Paper›PMID 34450047›Full record

ArticleCancer cell2021

Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer.

Mario Mairhofer, Lea Kausche, Sabine Kaltenbrunner, Riad Ghanem, Maike Stegemann, Katharina Klein, Maria Pammer, Isabella Rauscher, Helmut J F Salzer, Stefan Doppler and 7 more

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 9 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 9 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.Annals of oncology : official journal of the European Society for Medical Oncology · 2022
    Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Mario MairhoferMedical Department of Hematology and Oncology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Lea KauscheMedical Department of Hematology and Oncology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria; Medical Department of Hematology, Oncology and Tumor Immunology, and the Molecular Cancer Research Center, Charité - Universitätsmedizin Berlin, Germany.
Sabine KaltenbrunnerMedical Department of Hematology and Oncology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Riad GhanemMedical Department of Hematology and Oncology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Maike StegemannMedical Department of Hematology and Oncology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Katharina KleinMedical Department of Hematology and Oncology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Maria PammerMedical Department of Hematology and Oncology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Isabella RauscherMedical Department of Hematology and Oncology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Helmut J F SalzerMedical Department of Pulmonology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Stefan DopplerLaboratory Medicine at the Kepler University Hospital, Linz, Austria.
Anna HabringerLaboratory Medicine at the Kepler University Hospital, Linz, Austria.
Christian PaarLaboratory Medicine at the Kepler University Hospital, Linz, Austria.
Susanne KimeswengerMedical Department of Dermatology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Wolfram HoetzeneckerMedical Department of Dermatology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Bernd LamprechtMedical Department of Pulmonology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Soyoung LeeMedical Department of Hematology, Oncology and Tumor Immunology, and the Molecular Cancer Research Center, Charité - Universitätsmedizin Berlin, Germany; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany; Deutsches Konsortium für Translationale Krebsforschung (German Cancer Consortium), Berlin, Germany.
Clemens A SchmittMedical Department of Hematology and Oncology at the Kepler University Hospital, Johannes Kepler University, Linz, Austria; Medical Department of Hematology, Oncology and Tumor Immunology, and the Molecular Cancer Research Center, Charité - Universitätsmedizin Berlin, Germany; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany; Deutsches Konsortium für Translationale Krebsforschung (German Cancer Consortium), Berlin, Germany. Electronic address: clemens.schmitt@charite.de.
Johannes Kepler University of Linz · ATKepler Universitätsklinikum · ATMax Delbrück Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19NeoplasmsHumansImmunity, CellularRNA, MessengerSARS-CoV-2RNA, Messenger

Identifiers

PMID34450047
PMCPMC8367743
OpenAlexW3194536759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.